Globus Medical Raised to Overweight From Equal-Weight by Morgan Stanley
Globus Medical Analyst Ratings
Morgan Stanley Initiates Globus Medical(GMED.US) With Buy Rating, Announces Target Price $100
JMP Securities Maintains Globus Medical(GMED.US) With Hold Rating
Globus Medical's Strong Q3 Performance and Conservative Outlook Justify Hold Rating Amid Merger Challenges
Morgan Stanley Maintains Globus Medical(GMED.US) With Hold Rating, Raises Target Price to $83
Globus Medical Is Maintained at Equal-Weight by Morgan Stanley
Globus Medical Analyst Ratings
Barclays Maintains Globus Medical(GMED.US) With Buy Rating, Maintains Target Price $100
Stifel Maintains Globus Medical(GMED.US) With Buy Rating, Maintains Target Price $92
A Quick Look at Today's Ratings for Globus Medical(GMED.US), With a Forecast Between $85 to $100
Roth MKM Reiterates Buy on Globus Medical, Maintains $100 Price Target
What 7 Analyst Ratings Have To Say About Globus Medical
Globus Medical Is Maintained at Overweight by Piper Sandler
Globus Medical Price Target Raised to $100.00/Share From $80.00 by Piper Sandler
A Quick Look at Today's Ratings for Globus Medical(GMED.US), With a Forecast Between $85 to $100
B of A Securities Maintains Underperform on Globus Medical, Raises Price Target to $80
Globus Medical's Strong Q3 Performance and Optimistic Outlook Justify Buy Rating
Globus Medical Analyst Ratings
BTIG Sticks to Its Buy Rating for Globus Medical (GMED)